文献速递MDS 与骨髓增殖性肿瘤血栓与止血

年龄与诊断后时间对骨髓增殖性肿瘤患者血栓风险的影响:一项全国性登记匹配队列研究

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study.
PubMed 文献 · Br J Haematol · 2025-06-02

该全国性匹配队列研究利用瑞典登记数据,纳入2001至2021年诊断的17830例骨髓增殖性肿瘤患者,每例按性别、年龄和诊断年份匹配10名人群对照,评估达到年龄与诊断后时间对血栓风险的影响。结果显示患者各年龄段血栓发生率均显著较高,尤以诊断后2年内最高;诊断5年时65岁患者HR为1.8(95%CI 1.7-1.9),达到年龄较诊断后时间更重要。

要点

  • 骨髓增殖性肿瘤患者各年龄段血栓发生率均显著高于年龄匹配对照。
  • 诊断后2年内血栓发生率最高,之后仍高于年龄匹配对照。
  • 诊断5年时65岁患者任何血栓HR为1.8(95%CI 1.7-1.9)。

核心结论

  • 骨髓增殖性肿瘤患者血栓发生率在各年龄段均显著较高,诊断后2年内最高,达到年龄较诊断后时间更重要。

研究设计与样本

  • 全国性登记匹配队列研究,利用瑞典登记数据纳入2001至2021年诊断的17830例骨髓增殖性肿瘤患者,每例按性别、年龄和诊断年份匹配10名人群对照。
  • 采用灵活参数生存模型估计诊断后首次血栓发生率及风险比(HR),分析诊断后时间与达到年龄的影响。

主要发现

  • 骨髓增殖性肿瘤患者各年龄段血栓发生率均显著高于对照,诊断后2年内尤其明显,之后仍高于年龄匹配对照。
  • 诊断5年时任何血栓HR(95%CI)在65岁为1.8(1.7-1.9),70岁为1.6(1.5-1.7),75岁及以上为1.5(1.4-1.6),均为患者与对照比较。
  • 达到年龄较诊断后时间更重要,尤其在不伴既往血栓的患者中。
  • 血栓发生率在诊断后2年内最高,之后更多取决于达到年龄而非诊断后时间。

临床怎么用

  • 作者认为这些发现强调年龄和早期管理对优化骨髓增殖性肿瘤患者临床照护的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thromboembolism is one of the major complications in myeloproliferative neoplasms (MPNs), especially in the initial years post-diagnosis and with increasing age. This nationwide matched cohort study used Swedish registers to assess whether attained age or time since diagnosis is more important for thrombosis risk. We identified 17 830 MPN patients diagnosed between 2001 and 2021, each matched with 10 population controls by sex, age and diagnosis year. Rates of first thrombosis post diagnosis and hazard ratios (HRs) were estimated using flexible parametric survival models over time since diagnosis and attained age. Thrombosis rates were significantly higher in MPN patients at all ages, especially in the first 2 years post-diagnosis, after which the rates remained higher than in age-matched controls. At 5 years, HR (95% confidence interval) for any thrombosis comparing patients to controls was 1.8 (1.7-1.9) at age 65, 1.6 (1.5-1.7) at age 70 and 1.5 (1.4-1.6) at age 75 and older. Attained age was more important than time since diagnosis, particularly in patients without prior thrombosis. Thrombosis rates were highest within the first 2 years post-diagnosis, then depended more on attained age than on time since diagnosis. These findings emphasize the importance of age and early management in MPN patients to optimize clinical care.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Batyrbekova N, Hultcrantz M, Ravn Landtblom A, et al. Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study. Br J Haematol. 2025. PMID: 40457566. doi:10.1111/bjh.20141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。